Abstract
Background Prenatal vitamin use is recommended before and during pregnancies for normal fetal development. Prenatal vitamins do not have a standard formulation, but many contain calcium, folic acid, iodine, iron, omega-3 fatty acids, zinc, and vitamins A, B6, B12, and D, and usually they contain higher concentrations of folic acid and iron than regular multivitamins in the U.S. Nutrient levels can impact epigenetic factors such as DNA methylation, but relationships between maternal prenatal vitamin use and DNA methylation have been relatively understudied. We examined use of prenatal vitamins in the first month of pregnancy in relation to cord blood and placenta DNA methylation in two prospective pregnancy cohorts: the Early Autism Risk Longitudinal Investigation (EARLI) and Markers of Autism Risk Learning Early Signs (MARBLES) studies.
Results In placenta, prenatal vitamin intake was marginally associated with -0.52% (95% CI: - 1.04, 0.01) lower mean array-wide DNA methylation in EARLI, and associated with -0.60% (−1.08, -0.13) lower mean array-wide DNA methylation in MARBLES. There was little consistency in the associations between prenatal vitamin intake and single DNA methylation site effect estimates across cohorts and tissues, with only a few overlapping sites with correlated effect estimates. However, the single DNA methylation sites with p-value<0.01 (EARLI cord nCpGs=4,068, EARLI placenta nCpGs =3,647, MARBLES cord nCpGs =4,068, MARBLES placenta nCpGs=9,563) were consistently enriched in neuronal developmental pathways.
Conclusions Together, our findings suggest that prenatal vitamin intake in the first month of pregnancy may be related to lower placental global DNA methylation and related to DNA methylation in brain-related pathways in both placenta and cord blood.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nutrient and DNA methylation measures and analyses were supported by the National Institutes of Health (R01 ES025574, PI: Schmidt). Cord blood DNA methylation was also funded by R01 ES025531, PI: Fallin. Funding for the EARLI study was provided by the National Institutes of Health (R01ES016443, PI: Newschaffer) and Autism Speaks (003953 PI: Newschaffer). The MARBLES study was funded by National Institutes of Health grants (R24ES028533, R01ES020392, R01ES028089, R01ES020392, P01ES011269) and an EPA STAR grant (#RD-83329201). Support for this research was also provided by the National Institutes of Health grants (P30 ES017885 and R24 ES030893, PI: Fallin). Mr. Dou and Dr. Bakulski were also supported by grants (R01 ES025531, PI: Fallin; R01 AG067592, MPI: Bakulski; R01 MD013299). Dr. Zhu and Dr. LaSalle were supported by R01 ES029213. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Secondary data analysis for this manuscript was approved by the Human Subjects IRB for the University of Michigan.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available through the National Database for Autism Research (NDAR) accession numbers for EARLI (1600) and MARBLES (2462).
Abbreviations
- EARLI
- Early Autism Risk Longitudinal Investigation
- DHA
- Docosahexaenoic acid
- DMRs
- Differentially Methylated Regions
- LINE-1
- Long Interspersed Nuclear Element-1
- MARBLES
- Markers of Autism Risk Learning Early Signs